Theorem Clinical Research

Archives

Choose a date range

From To

Choose one or more categories

Categories:



Show only original CenterWatch stories

 


CluePoints wins ENTENTE Life Science Investment Forum Award

Thursday, October 30, 2014 01:32 PM

CluePoints, a provider of Centralized Statistical Monitoring (CSM) solutions for clinical trials, has secured an ENTENTE Life Science Investment Forum Award. The award program, which is organized by the ENTENTE project and supported by the European Commission and EuropaBio, recognized CluePoints as one of Belgium's most innovative high technology businesses for its Central Statistical Monitoring (CSM) solution, which employs unique statistical algorithms to determine the quality, accuracy and integrity of clinical trial data.

More... »


Charles River acquires ChanTest

Thursday, October 30, 2014 12:24 PM

Massachusetts-based CRO Charles River Laboratories International has acquired Cleveland-based ChanTest, a provider of specialized laboratory testing services for drug development, from Wellesley, Mass.-based Ampersand Capital Partners, in an all-cash transaction.

More... »


TNT launches TrialDat

Thursday, October 30, 2014 12:23 PM

TNT, a U.K. express delivery company, has launched TrialDat, a tool developed specifically for the clinical research sector, which captures end-to-end data on a single platform, offering a dashboard view of all clinical material transport flows.

More... »

BloodCenter of Wisconsin launches next-generation sequencing HemeOnc Panel

Thursday, October 30, 2014 12:22 PM

BloodCenter of Wisconsin's Diagnostic Laboratories has announced the availability of a comprehensive cancer mutation HemeOnc Panel using next-generation sequencing (NGS) technology. The NGS panel is designed to detect variants in 30 genes that are either prognostic or diagnostic for 10 different myeloid hematologic malignancies.

More... »

Abbott acquires medical device company Topera

Thursday, October 30, 2014 12:19 PM

Abbott has entered into an agreement to purchase Topera, a Menlo Park, Calif.-based, private, venture-backed medical device company focused on developing innovative electrophysiology technologies to improve the diagnosis and treatment of atrial fibrillation, one of the most common heart rhythm disorders in the world. Through this acquisition, Abbott enters the catheter-based electrophysiology market, an approximately $3 billion global market that has been growing annually at double-digit rates.

More... »

Report: Orphan drug market to reach $176B by 2020

Thursday, October 30, 2014 12:19 PM

In 2020 orphan drugs are expected to account for 19% of the total share of prescription drug sales excluding generics, reaching $176 billion in annual sales, according to the new EvaluatePharma Orphan Drug Report 2014 from London-based market intelligence firm Evaluate.

More... »

Booz Allen Hamilton acquires Epidemico

Thursday, October 30, 2014 12:15 PM

Booz Allen Hamilton, a Boston, Mass.-based provider of management consulting, technology and engineering services, has acquired Epidemico, a Boston informatics company.

More... »

eClinicalWorks chooses Exostar’s new identity proofing authentication service

Thursday, October 30, 2014 12:13 PM

Exostar, a Herndon, Va.-based information technology company offering cloud-based solutions that enable secure, cost-effective business-to-business collaboration, has launched its new turn-key, Software-as-a-Service (SaaS) identity proofing and second factor credential authentication solution, ProviderPass. eClinicalWorks, a Westborough, Mass.-based provider of ambulatory healthcare IT solutions, has selected ProviderPass to expand its comprehensive electronic health records (EHR) product suite to include electronic prescribing of controlled substances (EPCS).

More... »

Sanofi board ousts CEO Viehbacher

Thursday, October 30, 2014 08:46 AM

Paris-based biopharmaceutical company Sanofi ousted CEO Chris Viehbacher Wednesday, just two days after reporting disappointing quarterly earnings.

More... »

U.S. government institutes funding pause on gain-of-function research

Wednesday, October 29, 2014 01:39 PM

The U.S. government will undertake a deliberative process to assess the risks and benefits of certain gain-of-function (GOF) experiments with influenza, SARS and MERS viruses in order to develop a new federal policy regarding the funding of this research, announced Francis S. Collins, M.D., Ph.D., NIH director, in a statement. U.S. government agencies will institute a pause on the funding of any new studies involving these experiments.

More... »

CenterWatch Drugs in Clinical Trials
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

October 27

NIH’s I-Corps boot camp aims to transform researchers into better businesspeople before they launch products

Covance, Frenova form partnership to share patient databases, find effective treatments for renal disease

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

October

CROs driving changes in patient recruitment
Data- and tech-aided enrollment services a competitive advantage

Trials with in-home nurses poised to grow
Higher expense, but may improve recruitment and retention for select trials

Already a subscriber?
Log in to your digital subscription.

Purchase the October issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

September

Today's fastest, most economical sponsors
Standout sponsors reveal how they shorten regulatory, clinical cycle times

From the trenches: Sites' eye view of state of the industry
CW’s first site focus groups uncover frustration with 'progress,' but a passion for their mission

Already a subscriber?
Log in to your digital subscription.

Purchase the September issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs